NCRM Future Presentations

2, Nov 2024: World Psoriasis Day Hybrid-Online Seminar. Jointly Organized by Department of Dermatology, Thoothukudi Government Medical College, Tirunelveli-Thoothukudi-Kanyakumari Dermatologists' Association and Nichi-In Centre for Regenerative Medicine (NCRM).

27,Oct 2024: Abraham et al., A global, Inter-disciplinary interaction among scientists and clinicians to develop solutions for a rare genetic disease: Duchenne Muscular Dystrophy. Japanese Society of Social Medicine, Kyushu University of Medical Sciences, Miyazaki, Japan;

29, Sep 2024: Raghavan K. Summary of Clinical Trials on Neu-REFIX Beta 1,3-1,6 Glucans for Duchenne Muscular Dystrophy (DMD). Duchenne Awareness Day 2024.

26~29, Sep 2024: Abraham et al., Abraham SJK, Tsukada A, Miyajima I, Uchiyama S, Tabe D, Ikewaki N, Ichiyama K, Senthilkumar R, Iwasaki M. Biological Response Modifier Beta 1,3-1,6 Glucan, Nichi BRITE Improves Immunity, Hepatic Reserve, and De Ritis Ratio in Patients Undergoing Surgical Resection of Hepato-Biliary Malignancies; Outcome of a Clinical Study. 37th Annual National Conference, INDIAN ASSOCIATION OF SURGICAL ONCOLOGY, IASO NATCON 2024, Bengaluru.

13, Sep 2024: Abraham et al., From basics to translational research for 14-years unravelling the Anti-inflammatory potential of a novel b-glucan; moving to clinic in Duchenne muscular dystrophy " .Joint Conference of the 22nd Annual Meeting of Asian Oceanian Myology Center and the 10th Annual Meeting of Japan Muscle Society (AOMC-JMS 2024), Nara, Japan

12~15, Sep 2024: Aoki Y. Oral administration of Neu-REFIX Beta 1,3-1,6 Glucans reduces skeletal muscle fibrosis and fatigue in dystrophic mice. Joint Conference of The 22nd Annual Meeting of Asian and Oceanian Myology Center and The 10th Annual Meeting of Japan Muscle Society, Nara, Japan.